Literature DB >> 17177206

Role of tumor-derived proinflammatory cytokines GM-CSF, TNF-alpha, and IL-12 in the migration and differentiation of antigen-presenting cells in cervical carcinoma.

Henry J M A A Zijlmans1, Gert Jan Fleuren, Hans J Baelde, Paul H C Eilers, Gemma G Kenter, Arko Gorter.   

Abstract

BACKGROUND: Proinflammatory cytokines are important in modifying the activity, differentiation, and migration of antigen-presenting cells and may influence the survival of cancer patients. The study assessed whether GM-CSF, TNF-alpha, and IL-12, produced by cervical cancer cells, are important for the activity, differentiation, and migration of antigen-presenting cells.
METHODS: In 90 patients with cervical carcinoma the number of monocytes/tumor-associated macrophages (TAM), mature dendritic cells (DC), and Langerhans cells (LHC) was determined using immunohistochemistry. An RNA in situ hybridization technique was used to measure the expression level of GM-CSF, TNF-alpha, IL-12p35, and IL-12p40.
RESULTS: TAM were detected intraepithelial as well as in the stroma of the tumor. LHC were only detected intraepithelial and mature DC only in the tumor stroma. The number of TAM correlated positively with the number of mature DC. The expression levels of GM-CSF and TNF-alpha correlated positively with the number of TAM and DC. TNF-alpha showed a negative correlation with the number of LHC. A significant correlation between the expression of functional IL-12 (IL-12p40) and stromal TAM was found. The expression of GM-CSF, TNF-alpha, and IL-12p40 did not correlate significantly with disease-free survival. However, high IL-12p40 expression was associated with a favorable cumulative overall survival.
CONCLUSIONS: The results suggest that GM-CSF as well as TNF-alpha, produced by cervical carcinoma cells, may play a role in the differentiation of monocytes into mature DC. Furthermore, TNF-alpha may influence the migration of LHC from the tumor. (c) 2007 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17177206     DOI: 10.1002/cncr.22428

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer.

Authors:  Marlies Schrevel; E Michelle Osse; Frans A Prins; J Baptist M Z Trimbos; Gert Jan Fleuren; Arko Gorter; Ekaterina S Jordanova
Journal:  Int J Oncol       Date:  2017-05-03       Impact factor: 5.650

Review 2.  Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.

Authors:  Javid Sadri Nahand; Mohsen Moghoofei; Arash Salmaninejad; Zahra Bahmanpour; Mohammad Karimzadeh; Mitra Nasiri; Hamid Reza Mirzaei; Mohammad Hossein Pourhanifeh; Farah Bokharaei-Salim; Hamed Mirzaei; Michael R Hamblin
Journal:  Int J Cancer       Date:  2019-10-31       Impact factor: 7.396

3.  Immunosuppressive tumor microenvironment in cervical cancer patients.

Authors:  Sytse J Piersma
Journal:  Cancer Microenviron       Date:  2011-05-31

Review 4.  Novel GM-CSF-based vaccines: One small step in GM-CSF gene optimization, one giant leap for human vaccines.

Authors:  Ting-Wei Yu; Ho-Yen Chueh; Ching-Chou Tsai; Cheng-Tao Lin; Jiantai Timothy Qiu
Journal:  Hum Vaccin Immunother       Date:  2016-08-25       Impact factor: 3.452

Review 5.  Identification and manipulation of tumor associated macrophages in human cancers.

Authors:  Moniek Heusinkveld; Sjoerd H van der Burg
Journal:  J Transl Med       Date:  2011-12-16       Impact factor: 5.531

6.  Dysregulated expression of both the costimulatory CD28 and inhibitory CTLA-4 molecules in PB T cells of advanced cervical cancer patients suggests systemic immunosuppression related to disease progression.

Authors:  Agata Kosmaczewska; Dorota Bocko; Lidia Ciszak; Iwona Wlodarska-Polinska; Jan Kornafel; Aleksandra Szteblich; Anna Masternak; Irena Frydecka
Journal:  Pathol Oncol Res       Date:  2011-11-19       Impact factor: 3.201

7.  Immunotherapy of human papilloma virus induced disease.

Authors:  Sjoerd H van der Burg
Journal:  Open Virol J       Date:  2012-12-28

8.  Role of IL-12p40 in cervical carcinoma.

Authors:  H J M A A Zijlmans; S Punt; G J Fleuren; J B Trimbos; G G Kenter; A Gorter
Journal:  Br J Cancer       Date:  2012-10-25       Impact factor: 7.640

9.  Expression of endoglin (CD105) in cervical cancer.

Authors:  H J Zijlmans; G J Fleuren; S Hazelbag; C F Sier; E J Dreef; G G Kenter; A Gorter
Journal:  Br J Cancer       Date:  2009-04-07       Impact factor: 7.640

10.  Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Downregulates the Expression of Protumor Factors Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in a GM-CSF Receptor-Independent Manner in Cervical Cancer Cells.

Authors:  Nanyan Jiang; Zhiqiang Tian; Jun Tang; Rongying Ou; Yunsheng Xu
Journal:  Mediators Inflamm       Date:  2015-07-15       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.